The market for Asian sea bass market is expected to expand at a rate of 5% per year, from $960 million in 2023 to US$ 1,492 million in 2033. Because of their rapid reproduction and robustness, the supply has increased, allowing producers to expand output. It is anticipated that in 2023, the Asian sea bass market would …
Monthly Archives: February 2024
Revolutionizing Health: The Rise of Customized Phospholipid Formulations in Medicine and Agriculture | FMI
The phospholipid market is anticipated to grow at a 13.5% annual rate to reach US$ 4.64 billion by 2033. Using genetic profiles to create phospholipid solutions specific to each industry, customized formulations are transforming the medical sector. The phospholipid market is projected to be valued US$ 1.55 billion by 2023 and US$ 4.64 billion by …
Global Home Infusion Therapy Devices Market Poised for Significant Growth, Reaching US$ 4.4 Billion by 2033, with a 6.6% CAGR as per FMI
The global home infusion therapy devices market is on track to witness remarkable growth, with projections indicating a valuation of US$ 2.3 billion in 2023, escalating to an impressive US$ 4.4 billion by 2033. This surge is fueled by a notable compound annual growth rate (CAGR) of 6.6% throughout the forecast period, as revealed by …
Projected Surge: Oxo Alcohols Market to Hit US$ 23 Billion by 2033 with 5.8% CAGR
The oxo alcohols market is poised for significant growth, with projections indicating a value pool reaching US$ 13 billion by the end of 2022. This expansion is anticipated to continue at a steady pace, driven by increasing global demand, with expectations of reaching US$ 23 billion by 2033 at a compound annual growth rate (CAGR) …
Continue reading “Projected Surge: Oxo Alcohols Market to Hit US$ 23 Billion by 2033 with 5.8% CAGR”
Developmental and Epileptic Encephalopathies (DEE) Treatment Market Aims for US$ 11.4 Billion by 2033
The global Developmental and Epileptic Encephalopathies (DEE) Treatment Market is expected to expand at a compound annual growth rate (CAGR) of 5% between 2023 and 2033, from US$ 7 billion in 2023 to US$ 11.4 billion by 2033. The market for treatments for developmental and epileptic encephalopathies (DEE) grew at a compound annual growth rate …
Global Infection Prevention Market is set to grow at a 3.1% CAGR, reaching US$ 55,379.1 million by 2034 | FMI
The global infection prevention market is set to witness substantial growth over the next decade, according to a recent market analysis conducted by FMI. Estimated at over US$ 40,845.2 million in 2024, the market is expected to expand at a CAGR of 3.1% between 2024 and 2034, reaching a valuation of US$ 55,379.1 million by …
Chronic Hepatitis B Virus Testing Market Surges to Notable US$ 1790 Million Valuation in 2033
According to Future Market Insights, the chronic hepatitis B virus testing market sales is predicted to increase at a 6.9% compound annual growth rate (CAGR) from 2023 to 2033. It is anticipated that the worldwide market for testing for the chronic hepatitis B virus would reach a valuation of US$ 1790 million by 2033. The …
Tin Fluoborate Market Set to Reach US$ 10 Billion by 2033 with 5.2% CAGR
The tin fluoborate market is poised for significant growth, with projections indicating a value pool of US$ 6 billion by the end of 2023. Anticipated to continue its upward trajectory, global demand for tin fluoborate is forecasted to surge at a compound annual growth rate (CAGR) of 5.2%, reaching a substantial US$ 10 billion by …
Continue reading “Tin Fluoborate Market Set to Reach US$ 10 Billion by 2033 with 5.2% CAGR”
Global Advance Wound Care Industry is poised to achieve US$ 14,667.7 million by 2034, with a CAGR of 2.4% | FMI
The global advance wound care industry size is poised for remarkable growth, as indicated by recent market analysis conducted by FMI. Projections suggest a substantial increase in value, with estimates reaching US$ 11,521.11 million by 2024 and an anticipated surge to US$ 14,667.7 million by 2034. These insights reflect a steady compound annual growth rate …
Cardiogenic Shock Treatment Market Sees Noteworthy US$ 1.77 Billion Valuation by 2033| Future Market Insights
The global cardiac shock treatment market sales is expected to increase at a compound annual growth rate (CAGR) of 7% between 2023 and 2033, from US$ 0.9 billion in 2023 to US$ 1.77 billion by 2033. With a 3.5% compound annual growth rate, the market for cardiogenic shock treatment grew between 2018 and 2022. Cardiogenic …